WASHINGTON (dpa-AFX) - USANA Health Sciences, Inc. (USNA) announced, for fiscal 2020, the company projects: earnings per share of $4.00 - $4.90, revised from prior guidance range of $4.10 - $4.90. The company revised its earnings outlook modestly as a result of a lower effective tax rate and a lower diluted share count.
For fiscal 2020, USANA Health Sciences now targets consolidated net sales of $1.00 billion - $1.08 billion, a decline from previous guidance range of $1.03 billion - $1.13 billion. The company adjusted its net sales guidance to reflect an unfavorable shift in currency exchange rates, as well as an adjustment to reflect current assessment of future sales.
Copyright RTT News/dpa-AFX
USANA HEALTH SCIENCES-Aktie komplett kostenlos handeln - auf Smartbroker.de